Journals / Journal of Medicine and Palliative Care / 2023 / Cilt: 4 Sayı: 5

Evaluation of endothelial dysfunction and inflammation in recovered COVID-19 patients

İyileşmiş COVID-19 hastalarının endotel disfonksiyonu ve inflamasyonun değerlendirilmesi

Pages
511–515
Publication Date
2023-10-27
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There is a need for larger and multicenter studies on this subject.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: In our study, we aimed to evaluate the endothelial functions and hemogram parameters, which are considered as inflammation markers, in young people with a history of COVID-19 infection.
📊
Key Findings & Data:Methods: This prospective study included 109 recovered COVID-19 patients and 50 healthy controls.
💡
Conclusion & Impact:There is a need for larger and multicenter studies on this subject.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:endotel disfonksiyonu · Covid-19 · inflamasyon

Abstract

Aim: In our study, we aimed to evaluate the endothelial functions and hemogram parameters, which are considered as inflammation markers, in young people with a history of COVID-19 infection. Methods: This prospective study included 109 recovered COVID-19 patients and 50 healthy controls. Demographic characteristics, laboratory values and flow-mediated vasodilation test (FMD) results of the groups were compared. Results: Demographic and biochemistry parameters of the groups were similar. The calculated FMD values were significantly lower in the recovered COVID-19 patient group compared to the control group (8.66±3.31 vs 11.69±3.01; p= 0.001). While there was no difference between the groups in terms of neutrophil/lymphocyte ratio (NLR) and Platelet/Lymphocyte ratio (PLR), systemic immune-inflammation index (SII) was found to be higher in the patient group with recovered COVID-19 patients (p = 0.02). In correlation analysis, there was a low moderate negative correlation between FMD and SII (r = -0.35, p=0.002). Conclusion: FMD measurement and SII are simple, easily accessible parameters that can be useful in the early period to evaluate cardiovascular risks in the long term after COVID-19. There is a need for larger and multicenter studies on this subject.

Özet

Amaç: Çalışmamızda COVİD-19 enfeksiyonu geçirme hikayesi olan genç kişilerde endoteyal fonksiyonunu ve inflamasyon belirteci olarak kabul edilen hemogram parametrelerini değerlendirmeyi amaçladık. Yöntemler: Bu prospektif çalışmaya 109 iyileşen COVID-19 hastası ve 50 sağlıklı kontrol olgusu alındı. Grupların demografik özellikleri, laboratuvar değerleri ve akım aracılı vazodilatasyon testi (FMD) sonuçları karşılaştırılmıştır. Bulgular: Grupların demografik verileri ve biyokimya parametreleri benzerdi. Hesaplanan FMD değerleri COVID-19 geçiren hasta grubunda kontrol grubuna kıyasla anlamlı derecede daha düşüktü (8,66±3,31 ve 11,69±3,01; p= 0,001). Nötrofil/lenfosit oranı (NLR) ve Platelet/Lenfosit oranı (PLR) arasında gruplar arasında fark yokken, sistemik immün-inflamasyon indeksi (Sİİ) COVID-19 enfeksiyonu geçirmiş hasta grubunda daha yüksek saptandı (p = 0.02). Spearman korelasyon analizinde FMD ve SII arasında düşük orta derecede korelasyon saptandı (r=0.35, p=0.002). Sonuç: COVID-19 sonrası uzun vadede kardiyovasküler riskleri değerlendirmek amaçlı erken dönemde FMD ölçümü ve SII faydalı olabilecek basit, kolay ulaşılabilir parametrelerdir. Bu konu hakkında daha geniş çaplı ve çok merkezli çalışmalara ihtiyaç vardır.

🔖

Cite This Article

DOĞAN, Y., ÖZDEMIR, A. T. (2023). Evaluation of endothelial dysfunction and inflammation in recovered COVID-19 patients. Journal of Medicine and Palliative Care, Cilt: 4 Sayı: 5, 511–515. https://ajindex.com/articles/969310

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Xue G, Gan X, Wu Z, et al. Novel serological biomarkers for inflammation in predicting disease severity in patients with COVID-19. Int Immunopharmacol. 2020;89(PtA):107065. doi: 10.1016/j.intimp.2020.107065 Fois AG, Paliogiannis P, Scano V, et al. The systemic ınflammation ındex on admission predicts ın-hospital mortality in COVID-19 patients. Molecules. 2020;25(23):5725. doi:10.3390/molecules25235725 Salman E, Çelikbilek N, Aydoğan S, et al. Investigation of the relationship of systemic ımmune-ınflammation ındex, C-reactive protein and ınterleukin-6 with viral dynamics in patients with COVID-19]. Mikrobiyol Bul. 2021;55(4):539-552. doi:10.5578/mb.20219706 Magadum A, Kishore R. Cardiovascular manifestations of COVID-19 infection. Cells. 2020;9(11):2508. doi:10.3390/cells9112508 Yeboah J, Folsom AR, Burke GL, et al. Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis. Circulation. 2009;120(6):502-509. doi:10.1161/CIRCULATIONAHA.109.864801 Yang R, Chang Q, Meng X, Gao N, Wang W. Prognostic value of systemic immune-inflammation index in cancer: A meta-analysis. J Cancer. 2018;9(18):3295-3302
  2. Zhong JH, Huang DH, Chen ZY. Prognostic role of systemic immune-inflammation index in solid tumors: a systematic review and meta-analysis. Oncotarget. 2017;8(43):75381-75388.
  3. Shi S, Qin M, Shen B, et al. Association of cardiac ınjury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5(7):802-810. doi:10.1001/ jamacardio.2020.0950 Guo T, Fan Y, Chen M, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):811-818. doi:10.1001/jamacardio.2020.1017. Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683-690. doi:10.1001/ jamaneurol.2020.1127 Puntmann VO, Carerj ML, Wieters I, et al. Outcomes of cardiovascular magnetic resonance ımaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(11): 1265-1273. doi:10.1001/jamacardio.2020.3557 Fayol A, Livrozet M, Boutouyrie P, et al. Cardiac performance in patients hospitalized with COVID-19: a 6 month follow-up study. ESC Heart Fail. 2021;8(3):2232-2239. doi:10. 1002/ehf2.13315 Xie Y, Xu E, Bowe B, et al. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28(3):58